1. Home
  2. BHRB vs TBPH Comparison

BHRB vs TBPH Comparison

Compare BHRB & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burke & Herbert Financial Services Corp.

BHRB

Burke & Herbert Financial Services Corp.

HOLD

Current Price

$68.37

Market Cap

962.7M

Sector

Finance

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$19.42

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHRB
TBPH
Founded
1852
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
962.7M
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BHRB
TBPH
Price
$68.37
$19.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$71.67
$27.80
AVG Volume (30 Days)
79.5K
368.8K
Earning Date
01-22-2026
02-23-2026
Dividend Yield
3.22%
N/A
EPS Growth
173.76
N/A
EPS
7.72
0.58
Revenue
$340,508,000.00
$80,327,000.00
Revenue This Year
$37.10
$70.90
Revenue Next Year
$11.36
N/A
P/E Ratio
$8.84
$33.66
Revenue Growth
46.12
27.12
52 Week Low
$47.57
$7.90
52 Week High
$70.90
$21.03

Technical Indicators

Market Signals
Indicator
BHRB
TBPH
Relative Strength Index (RSI) 51.30 50.55
Support Level $63.33 $18.45
Resistance Level $70.90 $19.71
Average True Range (ATR) 1.45 0.80
MACD 0.11 -0.10
Stochastic Oscillator 46.90 51.63

Price Performance

Historical Comparison
BHRB
TBPH

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: